(Q41152423)

27 September 2017

1 reference

title

Treatment of theophylline overdose (English)

1 reference

27 September 2017

1 reference

Minton NA

1

1 reference

27 September 2017

Henry JA

series ordinal

2

1 reference

27 September 2017

language of work or name

English

0 references

publication date

1 October 1996

1 reference

American Journal of Emergency Medicine

27 September 2017

published in

1 reference

27 September 2017

volume

14

1 reference

27 September 2017

issue

6

1 reference

27 September 2017

page(s)

606-612

1 reference

Acute and chronic human toxicity of theophylline

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Theophylline poisoning

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Activated charcoal reborn. Progress in poison management

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Prevention of drug absorption in simulated theophylline overdose

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Treatment of theophylline poisoning.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Endoscopic removal of pharmacobezoar of slow release theophylline

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Treatment of theophylline intoxication

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Is there excessive use of gastric lavage in the treatment of self-poisoning?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Gastric aspiration and lavage in acute poisoning

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Changes in cardiorespiratory function during gastric lavage for drug overdose

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Syrup of ipecac in children less than one year of age

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Ipecac as a Cause of the Mallory-Weiss Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Massive theophylline overdose. Survival without hemoperfusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Severe theophylline toxicity. Role of conservative measures, antiarrhythmic agents, and charcoal hemoperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Haemoperfusion for theophylline overdose

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Acute pediatric theophylline overdose: a summary of 28 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Role of extracorporeal drug removal in acute theophylline poisoning. A review

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Emesis: Safe and effective?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Inefficacy of gastric emptying procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Ipecacuanha-induced emesis: a human model for testing antiemetic drug activity

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

A clinical trial using syrup of ipecac and activated charcoal concurrently

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Effect of charcoal-drug ratio on antidotal efficacy of oral activated charcoal in man

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Clinical pharmacokinetics of oral activated charcoal in acute intoxications

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Oral activated charcoal in the treatment of intoxications. Role of single and repeated doses

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Aspiration of activated charcoal

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Aspiration of activated charcoal and gastric contents

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Gastrointestinal obstruction associated with multiple-dose activated charcoal

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Intestinal pseudo-obstruction following the use of enteral charcoal and sorbitol and mechanical ventilation with papaveretum sedation for theophylline poisoning

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Cathartics and laxatives. Do they still have a place in management of the poisoned patient?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

How useful is activated charcoal?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Model for theophylline overdose treatment with oral activated charcoal.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Treatment of theophylline toxicity with oral activated charcoal

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Theophylline absorption by effervescent activated charcoal (Medicoal)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Absorption inhibition and enhancement of elimination of sustained-release theophylline tablets by oral activated charcoal

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

The comparative efficacy of various multiple-dose activated charcoal regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Prevention of drug absorption in simulated theophylline overdose

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Role of repeated oral doses of activated charcoal in clinical toxicology

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Intravenous theophylline poisoning and multiple-dose charcoal in an animal model.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Studies on the mechanisms of action of activated charcoal on theophylline pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Gastrointestinal clearance of drugs with activated charcoal

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

The effects of charcoal and sorbitol (alone and in combination) on plasma theophylline concentrations after a sustained-release formulation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

The effect of sorbitol and activated charcoal on serum theophylline concentrations after slow-release theophylline.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Gastrointestinal transit times of cathartics combined with charcoal.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Evaluation of activated charcoal-sodium sulfate combination for inhibition of acetaminophen absorption and repletion of inorganic sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Evaluation of a Charcoal-Sorbitol Mixture as an Antidote for Oral Aspirin Overdose

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Sorbitol catharsis does not enhance efficacy of charcoal in a simulated acetaminophen overdose.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Effect of purgatives on antidotal efficacy of oral activated charcoal

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Saline Catharsis: Effect on Aspirin Bioavailability in Combination with Activated Charcoal

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Magnesium toxicity secondary to catharsis during management of theophylline poisoning

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Hypermagnesemia. A potential complication during treatment of theophylline intoxication with oral activated charcoal and magnesium-containing cathartics

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Severe hypernatremic dehydration after use of an activated charcoal-sorbitol suspension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Repetitive doses of the activated charcoal-sorbitol combination: A word of caution

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Whole bowel irrigation as a gastrointestinal decontamination procedure after acute poisoning

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Theophylline desorption from activated charcoal caused by whole bowel irrigation solution

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Enhancement of theophylline clearance by oral activated charcoal

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Effects of size and frequency of oral doses of charcoal on theophylline clearance

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Severe theophylline poisoning: charcoal haemoperfusion or haemodialysis?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Peritoneal Clearance of Theophylline

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Treatment of Theophylline Neurotoxicity with Resin Hemoperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Haemoperfusion: a useful therapy for a severely poisoned patient?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Charcoal hemoperfusion treatment of severe theophylline toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Use of hemoperfusion for treatment of theophylline intoxication

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Management of theophylline intoxication with charcoal-column hemoperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Benefit of hemoperfusion in acute theophylline intoxication

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Theophylline poisoning in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Metabolic abnormalities associated with intentional theophylline overdose

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Self-poisoning with sustained-release aminophylline: a mechanism for observed secondary rise in serum theophylline.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Theophylline toxicity: clinical features of 116 consecutive cases

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Hemolysis following treatment of theophylline overdose with coated charcoal hemoperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Predictors of major toxicity after theophylline overdose

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Repetitive oral activated charcoal and control of emesis in severe theophylline toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Characteristics of vomiting associated with acute sustained release theophylline poisoning: implications for management with oral activated charcoal

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Neuropharmacology of emesis induced by anti-cancer therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Ondansetron in the treatment of theophylline overdose

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Ondansetron in the treatment of intractable nausea associated with theophylline toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Bronchodilator Effects on Gastric Acid Secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Inhibition of Theophylline Clearance by Cimetidine but not Ranitidine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Cimetidine inhibits theophylline clearance in patients with chronic obstructive pulmonary disease: a study using stable isotope methodology during multiple oral dose administration

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Ranitidine and Theophylline

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Ranitidine and theophylline

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Pharmacokinetic Interactions Between Theophylline and Other Medication (Part II)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Propranolol administration in theophylline overdose

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Theophylline toxicity and the beta-adrenergic system

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Acute theophylline toxicity and the use of esmolol to reverse cardiovascular instability

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Toxicity of salbutamol and theophylline together

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Modulation of the effects of salbutamol by propranolol and atenolol

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Adverse reactions and interactions with theophylline

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Treatment of multifocal atrial tachycardia with verapamil

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Proarrhythmia related to a kinetic and dynamic interaction of mexiletine and theophylline

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Influence of mexiletine on the pharmacokinetics of theophylline in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

On the mechanism of action of theophylline and caffeine.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Pharmacodynamic Interactions Between Infused Adenosine and Oral Theophylline

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Bronchospasm induced by intravenous adenosine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Fatal overdose from a sustained-release theophylline preparation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Focal seizures and aminophylline

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Adenosine receptors are not involved in theophylline-induced seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

Relative efficacy of phenytoin and phenobarbital for the prevention of theophylline-induced seizures in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2896%2990111-4

7 January 2021

10.1016/S0735-6757(96)90111-4

Identifiers

DOI

1 reference

27 September 2017

1 reference